According to Illumina's latest financial reports the company's current EPS (TTM) is -$26.39. In 2021 the company made an earnings per share (EPS) of $5.09 an increase over its 2020 EPS that were of $4.48.
Year | EPS | Change |
---|---|---|
2022 (TTM) | -$26.39 | -618.47% |
2021 | $5.09 | 13.62% |
2020 | $4.48 | -34.21% |
2019 | $6.81 | 21.17% |
2018 | $5.62 | 12.4% |
2017 | $5.00 | 58.23% |
2016 | $3.16 | -0.94% |
2015 | $3.19 | 24.12% |
2014 | $2.57 | 157% |
2013 | $1.00 | -18.03% |
2012 | $1.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $17.93 | -167.94% | ๐บ๐ธ USA |
![]() Agilent Technologies A | $4.20 | -115.92% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $10.36 | -139.26% | ๐บ๐ธ USA |
![]() Danaher DHR | $9.79 | -137.10% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $4.92 | -118.64% | ๐บ๐ธ USA |
![]() Pacific Biosciences
PACB | -$1.34 | -94.92% | ๐บ๐ธ USA |